NCT06703840View on ClinicalTrials.gov

Phase 2a Trial to Investigate the Efficacy of LIB-01 in Treatment of Erectile Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

November 8, 2024

Primary Completion Date

July 19, 2025

Study Completion Date

August 19, 2025

Conditions
Erectile Dysfunction
Interventions
DRUG

LIB-01

LIB-01 oral suspension

DRUG

LIB-01 Placebo

LIB-01 Placebo oral suspension

Trial Locations (6)

2730

Herlev Hospital, Herlev

75237

Clinical Trial Consultants, Uppsala

9713 GZ

Clinical Trial Consultants, Groningen

431 53

Clinical Trial Consultants, Mölndal

582 13

Clinical Trial Consultants, Linköping

171 64

Clinical Trial Consultants, Solna

Sponsors

Lead Sponsor

Dicot AB
All Listed Sponsors
lead

Dicot AB

INDUSTRY

NCT06703840 - Phase 2a Trial to Investigate the Efficacy of LIB-01 in Treatment of Erectile Dysfunction | Biotech Hunter | Biotech Hunter